Skip to main content
Progesterone (Luteal) · Normal: 2-25 ng/mL · Optimal: 10-25 ng/mL

What Is Progesterone (Luteal Phase)? Normal vs Optimal Range Explained

Luteal phase progesterone measures the output of the corpus luteum—the structure formed after ovulation that produces progesterone to prepare the uterine lining for pregnancy. Standard lab ranges span 2–25 ng/mL, but optimal luteal function requires 10–25 ng/mL at mid-luteal peak (days 19–22). Values below 10 ng/mL suggest anovulation, inadequate ovulation, or luteal phase defect.

Want to check YOUR levels? Upload labs freeFree, 10 seconds →

Data sourced from CTD, PubMed, FAERS. How we verify this data →
Sources verified as of April 2026
[01]

Normal vs Optimal Range

Lab Normal Range: 225 ng/mL
Optimal: 1025 ng/mL
2 ng/mL25 ng/mL
Lab NormalOptimal

Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.

Range TypeLowHighUnit
Lab Normal225ng/mL
Optimal1025ng/mL
[02]

Why Optimal Matters

The standard lab range for luteal progesterone spans 2–25 ng/mL, but this enormous range includes values that indicate failed or absent ovulation. A mid-luteal progesterone of 3 ng/mL technically falls within the reference range, yet it means the corpus luteum is barely functioning—the uterine lining is insufficiently prepared for implantation and the luteal phase is likely shortened. The CTD maps over 1,800 gene–chemical interactions for progesterone and its receptor pathways, confirming progesterone's essential roles in uterine receptivity, pregnancy maintenance, nervous system calming, and breast tissue regulation. For fertility assessment, a mid-luteal progesterone below 10 ng/mL strongly suggests inadequate ovulation or a luteal phase defect—one of the most common and most treatable causes of infertility and early pregnancy loss.

Progesterone's clinical importance extends far beyond reproduction. It is a potent neurosteroid that enhances GABA-A receptor function, producing calming and sleep-promoting effects. The characteristic premenstrual symptoms experienced by many women—anxiety, insomnia, irritability, bloating—occur precisely during the luteal phase when progesterone should be high but is often suboptimal. PubMed indexes over 9,600 publications on progesterone in human reproductive and neurological function, establishing that adequate luteal progesterone supports mood stability, sleep quality, and anxiety reduction through direct GABAergic effects. The FAERS database logs over 4,200 adverse event reports involving hormonal medications that affect progesterone levels, including oral contraceptives and progestins.

Targeting mid-luteal progesterone at 10–25 ng/mL confirms robust ovulation and adequate corpus luteum function. Timing is critical for interpretation—progesterone must be measured 7 days after ovulation (roughly days 19–22 of a 28-day cycle) to capture the luteal peak. A single low reading should be confirmed with a repeat test the following cycle, as occasional anovulatory cycles are normal. Persistent low luteal progesterone across multiple cycles warrants investigation for hypothalamic dysfunction, thyroid disorders (hypothyroidism suppresses ovulation), hyperprolactinemia, and PCOS—all of which impair corpus luteum development and progesterone production through different mechanisms.

Want to see where YOUR levels fall?

Upload labs free — instant results →
[03]

Symptoms When Low

Premenstrual anxiety, irritability, and mood swings from inadequate GABAergic effectsInsomnia or disrupted sleep during the second half of the menstrual cycleSpotting or bleeding before the expected period (shortened luteal phase)Difficulty conceiving or early pregnancy loss from inadequate uterine preparationBreast tenderness and bloating disproportionate to cycle phaseHeavy or prolonged menstrual periods from unopposed estrogen effects
[04]

Symptoms When High

Excessive drowsiness and fatigue—progesterone's sedating GABAergic effect in overdriveBloating and fluid retentionBreast fullness and tendernessConstipation from smooth muscle relaxation in the GI tract
[05]

What Affects This Marker

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD). Over 1,800 gene–chemical interactions mapped for progesterone receptor pathways. North Carolina State University, 2025.
  2. [2]PubMed. Over 9,600 indexed publications on progesterone in reproductive and neurological function. National Library of Medicine.
  3. [3]FDA Adverse Event Reporting System (FAERS). Over 4,200 adverse event reports involving hormonal medications affecting progesterone. FDA, 2025.
  4. [4]Practice Committee of the American Society for Reproductive Medicine. Current clinical irrelevance of luteal phase deficiency: a committee opinion. Fertility and Sterility. 2015;103(4):e27-e32. PMID: 25681857.
  5. [5]Schiller CE, Johnson SL, Abate AC, et al. Reproductive steroid regulation of mood and behavior. Comprehensive Physiology. 2016;6(3):1135-1160. PMID: 27347888.
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Upload Your Lab Results

See where your levels fall on the optimal scale.

Upload Labs Free →